20 commercial payer policies list J3304. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
20 policies from 11 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Status of J3304 |
|---|---|---|
| Triamcinolone Acetonide Extended-Release Injectable Suspension (Zilretta ) | Dec 1, 2022 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Triamcinolone Acetonide Extended-Release Injectable Suspension (Zilretta) | Mar 9, 2018 | Prior auth requiredInferred from policy title |
| Triamcinolone Acetonide Extended-Release Injectable Suspension (Zilretta) | Jan 1, 2021 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Triamcinolone Acetonide Extended-Release Injectable Suspension (Zilretta) | Dec 1, 2019 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Zilretta (triamcinolone acetonide extended-release inject susp) | Nov 1, 2023 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Zilretta (triamcinolone acetonide extended-release injectable suspension) | Nov 1, 2025 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Zilretta (triamcinolone acetonide extended-release injectable suspension) | Nov 1, 2024 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Policy | Effective | Status of J3304 |
|---|---|---|
| Back Pain - Invasive Procedures | Mar 13, 2024 | Covered |
| Knee Arthroscopy / Osteoarthritis of the Knee | Nov 21, 2023 | Covered |
| Policy | Effective | Status of J3304 |
|---|---|---|
| Triamcinolone Acetonide ER Injectable (Zilretta) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Triamcinolone Acetonide Extended-Release Injectable (Zilretta) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3304 |
|---|---|---|
| Triamcinolone Acetonide ER Injectable (Zilretta) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Triamcinolone Acetonide Extended-Release Injectable (Zilretta) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3304 |
|---|---|---|
| Triamcinolone Acetonide Extended Release (e.g., Zilretta) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3304 |
|---|---|---|
| ZILRETTA (TRIAMCINOLONE ACETONICE) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3304 |
|---|---|---|
| Zilretta | Jul 1, 2023 | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3304 |
|---|---|---|
| Triamcinolone ER Injection (Zilretta); CP.PHAR.371 | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3304 |
|---|---|---|
| Triamcinolone Acetonide Extended-Release (Zilretta) | Feb 11, 2020 | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3304 |
|---|---|---|
| 00612 triamcinolone extended release intra-articular injection (Zilretta) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3304 |
|---|---|---|
| Zilretta (triamcinolone acetonide ER) Listed in Moda Health's provider indexes for Oregon, Alaska, Idaho, Texas. The document does not establish the member's state or line of business. | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |